SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

FEMY

Femasys Inc.
NASDAQHealth Care

Latest close: 1.65 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 14, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  2. Aug 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 11, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record29410 flagged findings
Reported transactions (Form 4)51since Jun 2, 2025 · and 19 other holdings
Corporate events (8-K)30since Feb 24, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Reverse splits in 5 years

1 reverse split in 5 years (1:20 on Jun 8, 2026) · 1:20 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 294)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 15, 26SCHEDULE 13G ↗Passive stake · Empery Asset Management, LP · 5.6% · event on Sep 30, 26 new
  • Sep 29, 26424B3 ↗Securities offering
  • Sep 3, 26S-3 ↗Securities offering
  • Aug 31, 26SCHEDULE 13G ↗Passive stake · Stonepine Capital Management, LLC · 7.2% · event on Aug 10, 26
  • Aug 17, 26SCHEDULE 13D ↗Stake with intent to influence · Nantahala Capital Partners Limited Partnership · 10.0% · event on Aug 10, 26
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · Rosalind Advisors, Inc. · 9.9% · event on Aug 10, 26
  • Aug 14, 2610-Q ↗Quarterly report
  • Aug 14, 268-K ↗Current report · Results
  • Insider transaction · 6 Form 4 filingsshow all 6hide
  • Aug 11, 26Form 3 ↗Insider transaction
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Aug 11, 268-K ↗Current report · Entered a material agreement
  • Jun 24, 268-K ↗Current report · Shareholder vote results
  • Jun 24, 268-K ↗Current report · Other events
  • Jun 5, 268-K ↗Current report · Change in shareholder rights · Bylaws or fiscal year change
  • Jun 4, 268-K ↗Current report · Communication to the market
  • May 13, 268-K ↗Current report · Communication to the market

294 filings on record, the oldest from Mar 10, 21.

Listing the 25 most recent filings of the 294 on record.

8-Ks, explained

Stress6Structure16Governance9
  • Aug 11, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Apr 1, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Mar 20, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jan 15, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 7, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Oct 21, 25StressListing notice (8-K 3.01)+1 more in the same filing · nominal item 3.01: the filing covers another matter8-K 3.01 ↗
  • Oct 17, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Aug 27, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jul 18, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jul 3, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jun 2, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • May 23, 25StressListing notice (8-K 3.01)8-K 3.01 ↗

7 older filings not shown · The record reaches back to Jan 20, 22.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Nov 15, 23StressListing notice (8-K 3.01)+5 more in the same filing8-K 3.01 ↗
  • Jun 2, 23StressListing notice (8-K 3.01)8-K 3.01 ↗

The full record holds 6 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Nantahala Capital Partners Limited Partnership10.0%Aug 10, 26SCHEDULE 13D ↗4 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Alumni Capital LP10.0%Sep 4, 25SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Rosalind Advisors, Inc.9.9%Aug 10, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Dauntless Investment Group, LLC9.9%Sep 30, 25SCHEDULE 13G/A ↗1 earlier filing
  • Chernett Jorey9.3%Jun 30, 25SCHEDULE 13G/A ↗1 earlier filing
  • PharmaCyte Biotech, Inc.7.9%Mar 17, 26SCHEDULE 13G ↗
show 2 more holdershide
  • Stonepine Capital Management, LLC7.2%Aug 10, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Empery Asset Management, LP5.6%Sep 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 7, 26Buy$50KKathy Lee-SepsickChief Executive Officer↗
  • Aug 7, 26Buy$50KDov ElefantChief Financial Officer↗
  • Aug 7, 26Buy$14KJohn Charles CanningChief Operating Officer↗
  • Aug 7, 26Buy$10KJeremy Alexander SiposChief Technology Officer↗
  • Aug 7, 26Buy$10KJeffrey Gerald MifekChief Clinical-Medical Affairs↗
Stock compensation, tax and giftsshow the 6 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 27, 25Otheramount n/aKathy Lee-SepsickChief Executive Officer↗
  • Aug 27, 25Otheramount n/aDov ElefantChief Financial Officer↗
  • Jun 2, 25Other$35KKathy Lee-SepsickChief Executive Officer↗
  • Jun 2, 25Other$20KDov ElefantChief Financial Officer↗
  • Jun 2, 25Other$20KDaniel Scott CurrieChief Operating Officer↗
  • Jun 2, 25Other$25KCharles Larsen↗

The full record holds 11 transactions and goes back to Jun 14, 23.

Its sector and its market

Femasys Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Femasys Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Femasys Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
294 documents on file, from Mar 10, 2021 to Oct 15, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.